摘要
Abstract
Objective To investigate the effects of atorvastatin on detecting serum levels of H-FABP, hs-CRP, IMA and changes in cardiac function of patients with acute myocardial infarction. Methods A total of 78 patients with acute myocardial infarction cured in our hospital from January 2014 to January 2015 were selected and divided into two groups(control group and treatment group) follow treatment methods. Patients in control group were given general treatment, and patients in treatment group were given extra atorvastatin on the basis. Two groups treated for 3 days, H-FABP, hs-CRP, IMA, cardiac function for 7 days, adverse cardiovascular events for 1 year of the two groups were compared. Results The levels of H-FABP, hs-CRP, IMA of treatment group were significantly lower than those of control group after treatment(P<0.05). The LVEF of treatment group was significantly higher than that of control group, while LVEDD and IVST of treatment group were significantly better than those of control group(P<0.05). One year follow-up, heart again incident of treatment group was obviously lower than those of control group(P<0.05). Conclusion Atorvastatin can effectively improve the cardiac function of patients with acute myocardial, effectively reduce the degree of blood fat and inflammatory reaction infarction, and reduce the incidence of adverse cardiovascular events. It is safe and reliable.关键词
阿托伐他汀/急性心肌梗死/心功能/H-FABP/hs-CRP/IMA/心血管事件Key words
Atorvastatin/Acute myocardial infarction/Cardiac function/H-FABP/hs-CRP/IMA/Cardiovascular events分类
医药卫生
